Foundation Knee Study - Retrospective

Sponsor
Encore Medical, L.P. (Industry)
Overall Status
Terminated
CT.gov ID
NCT00764894
Collaborator
(none)
200
1
40
5

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the use and efficacy of the Encore Foundation Knee System in a group of 200 patients for whom data has already been collected.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Post-Market Study of the Foundation Knee System
Study Start Date :
Oct 1, 2007
Actual Primary Completion Date :
Feb 1, 2011
Actual Study Completion Date :
Feb 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Foundation Knee

Retrospective data collection on 510(k) approved device

Device: Foundation Knee
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis who received a primary Foundation Knee replacement and is willing to participate in the study.

Outcome Measures

Primary Outcome Measures

  1. The use and efficacy of the Encore Foundation Knee System [2 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Have knee joint disease related to one or more of the following

  • osteoarthritis

  • post-traumatic arthritis

  • inflammatory tissue disorders

  • arthritis secondary to other diseases

  • Avascular necrosis of the femoral condyles;

  • Skeletal maturity

  • Less than 70 on the Knee Society Score (rating score)

  • Sufficient bone stock, as judged by radiographs, to support primary knee implant

  • Sufficient collateral ligaments to support the device, as judged by physician during stability testing (varus/valgus and flexion/extension) and less than 45 degree varus/valgus deformity and/or 90 degree flexion contracture

  • Patient is likely to be available for evaluation for the duration of the study

  • Able and willing to sign the informed consent and follow study procedures

  • Patient is not pregnant

  • No infection present

  • No known materials sensitivity

Exclusion Criteria:
  • Skeletal immaturity

  • Greater than or equal to 70 on preoperative Knee Society Score (Rating Score)

  • Post-patellectomy

  • Insufficient bone quality which may affect implant stability

  • Insufficient collateral ligaments, as judged by the physician. Greater than 45 degree varus/valgus deformity and/or 90 degree flexion contracture.

  • Neurological conditions that might hinder patient's ability to follow study procedures (i.e., any that restrict physical activities such as Parkinson's Disease, Multiple Sclerosis, previous stroke which affects lower extremity)

  • Mental conditions that may interfere with ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the patient cannot understand the informed consent process, global dementia, prior strokes that interfere with the patient's cognitive abilities, senile dementia, and Alzheimer's Disease)

  • Prisoners

  • Conditions that place excessive demand on the implant (i.e. Charcot's joints, muscle deficiencies, refusal to modify postoperative physical activities, skeletal immaturity)

  • Patient is pregnant

  • Infection present

  • Materials sensitivity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hussamy Orthopedics Vero Beach Florida United States 32960

Sponsors and Collaborators

  • Encore Medical, L.P.

Investigators

  • Principal Investigator: Omar Hussamy, M.D., Hussamy Orthopedics

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00764894
Other Study ID Numbers:
  • PS - 701
First Posted:
Oct 2, 2008
Last Update Posted:
Feb 9, 2011
Last Verified:
Feb 1, 2011
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2011